Darunavir and telaprevir drug interaction: total and unbound plasma concentrations in HIV/HCV-coinfected patients with cirrhosis.
about
Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.
P2860
Darunavir and telaprevir drug interaction: total and unbound plasma concentrations in HIV/HCV-coinfected patients with cirrhosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@en
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@nl
type
label
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@en
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@nl
prefLabel
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@en
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@nl
P356
P1476
Darunavir and telaprevir drug ...... ected patients with cirrhosis.
@en
P2093
Josep Maria Guiu
Manuel Crespo
P304
P356
10.1093/JAC/DKT509
P407
P577
2013-12-19T00:00:00Z